References
- De Oliveira FF, Bertolucci PH, Chen ES, et al. Assessment of risk factors for earlier onset of sporadic Alzheimer's disease dementia. Neurol India. 2014;62:625–630.
- Oliveira FF, Chen ES, Smith MC, et al. Predictors of cognitive and functional decline in patients with Alzheimer disease dementia from Brazil. Alzheimer Dis Assoc Disord. 2016;30:243–250.
- De Oliveira FF, Chen ES, Smith MC, et al. Associations of blood pressure with functional and cognitive changes in patients with Alzheimer's disease. Dement Geriatr Cogn Disord. 2016;41:314–323.
- Mehrabian S, Raycheva M, Gateva A, et al. Cognitive dysfunction profile and arterial stiffness in type 2 diabetes. J Neurol Sci. 2012;322:152–156.
- Beeri MS, Rapp M, Silverman JM, et al. Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers. Neurology. 2006;66:1399–1404.
- De Oliveira FF, Chen ES, Smith MC, et al. Longitudinal lipid profile variations and clinical change in Alzheimer's disease dementia. Neurosci Lett. 2017;646:36–42.
- McKhann GM, Knopman DS, Chertkow H, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7:263–269.
- De Oliveira FF, Wajman JR, Bertolucci PHF, et al. Correlations among cognitive and behavioural assessments in patients with dementia due to Alzheimer's disease. Clin Neurol Neurosurg. 2015;135:27–33.
- Chaves MLF, Camozzato AL, Godinho C, et al. Validity of the clinical dementia rating scale for the detection and staging of dementia in Brazilian patients. Alzheimer Dis Assoc Disord. 2007;21:210–217.
- Folstein MF, Folstein S, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189–198.
- Katz S, Akpom CA. A measure of primary socio-biological functions. Int J Health Serv. 1976;6:493–508.
- Lawton MP. Instrumental Activities of Daily Living (IADL) scale: self-reported version. Psychopharmacol Bull. 1988;24:789–791.
- Cockroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31–41.
- Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2486–2497.
- Sharp ES, Gatz M. Relationship between education and dementia: an updated systematic review. Alzheimer Dis Assoc Disord. 2011;25:289–304.
- Soldan A, Pettigrew C, Cai Q, et al. Cognitive reserve and long-term change in cognition in aging and preclinical Alzheimer's disease. Neurobiol Aging. 2017;60:164–172.
- Buchman AS, Wilson RS, Bienias JL, et al. Change in body mass index and risk of incident Alzheimer disease. Neurology 2005;65:892–897.
- Kandiah N, Chander RJ, Ng A, et al. Association between white matter hyperintensity and medial temporal atrophy at various stages of Alzheimer's disease. Eur J Neurol. 2015;22:150–155.
- Deschaintre Y, Richard F, Leys D, et al. Treatment of vascular risk factors is associated with slower decline in Alzheimer disease. Neurology. 2009;73:674–680.
- West RK, Moshier E, Lubitz I, et al. Dietary advanced glycation end products are associated with decline in memory in young elderly. Mech Ageing Dev. 2014;140:10–12.